IQInvest
Sign in

PM

Philip Morris International Inc.

NYQ · Consumer Defensive

$192.69

$1.23 (+0.64%)up 0.64%

25 August 2026 · delayed 15+ min

D-

Quality score60.8 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

Philip Morris International Inc. earns a D- on excellent profit margins (>20%) and positive free cash flow but current ratio below 1.0 (liquidity concerns) and negative earnings growth. Consider alternatives with better risk/reward profiles.

Model stance WEAK HOLD Suggested position 4.0% · $400.00 IQInvest estimate
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in dollars.

IQ-PM-20260825engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

52-week low

$142.11

Lowest analyst target

$175.00

Today's price

$192.69

Mean analyst target

$203.80

52-week high

$207.76

Highest analyst target

$225.00

PM trades 77% of the way up its 52-week range, between $142.11 and $207.76. The mean analyst target of $203.80 is 5.8% above today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthExcellent profit margins (>20%); Positive free cash flow; Current ratio below 1.0 (liquidity concerns); Negative earnings growth 65.023%

Profit margin

25.56%

Net profit per unit of revenue

exceptionalWhat this means

Of every 100 units of revenue, this much survives as profit.

Margins this wide usually mean real pricing power or a moat.

Operating margin

40.00%

Before interest and tax

very highWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

Typical of software and other businesses with little cost per extra sale.

Gross margin

67.48%

After the cost of goods only

highWhat this means

What is left of revenue after only the direct cost of the product.

Little marginal cost per sale, which is what lets software and pharma fund heavy R&D.

Return on assets

14.59%

Profit per unit of assets

strongWhat this means

Profit generated per unit of everything the company owns.

The assets are working hard.

Current ratio

0.98

Short-term assets over short-term debts

tightWhat this means

Short-term assets against short-term obligations.

Below 1 the company owes more within a year than it holds — workable if customers pay up front, risky otherwise.

Quick ratio

0.47

As above, excluding inventory

tightWhat this means

Short-term assets excluding inventory, against short-term debts.

Very little liquid cover if receipts slow down.

Revenue growth

10.40%

Year on year

growingWhat this means

Change in revenue against the same period last year.

A healthy expansion rate.

Earnings growth

-7.50%

Year on year

fallingWhat this means

Change in earnings against the same period last year.

Profit is declining even if revenue is not.

Revenue

$21.34B

Trailing twelve months

Free cash flow

$9.71B

Cash left after capital spending

Operating cash flow

$14.26B

Cash from the business itself

Payout ratio

80.73%

Dividends as a share of earnings

above earningsWhat this means

The share of earnings paid out as dividends.

The dividend exceeds profit, so it is being funded from cash or debt — rarely sustainable.

Growth & momentum11 measured figures 70.022%

Return, 1 month

-3.74%

Return, 3 months

6.73%

Return, 6 months

3.28%

Return, year to date

22.28%

Return, 1 year

19.30%

Return, 3 years

132.28%

Sharpe ratio

0.79

Return earned per unit of risk

modestWhat this means

Return earned per unit of risk taken.

Below 1 is the common case; return did not strongly outpace the volatility.

Win rate

55.18%

Share of days that closed up

consistently positiveWhat this means

The share of trading days that closed higher.

More up days than most shares manage.

Average daily return

0.08%

Best day

10.95%

Worst day

-8.43%

ValuationHigh PEG ratio (2.45) 25.018%

P/E ratio

26.47

Price against trailing earnings

highWhat this means

You pay 26.47 for every 1 unit of annual earnings.

Above about 25 the market is paying up for expected growth.

Forward P/E

21.02

Price against forecast earnings

moderateWhat this means

Price against next year's *forecast* earnings.

A conventional range.

PEG ratio

2.45

P/E adjusted for growth

expensive for the growthWhat this means

P/E divided by the growth rate — it asks whether the price is justified by the growth.

Above 2 you pay more per unit of growth than the convention treats as reasonable.

Price to book

-34.99

Price against balance-sheet equity

below bookWhat this means

Price against the accounting value of the company's net assets.

Under 1 the market values the company at less than its balance sheet — common in banks, and in businesses the market distrusts.

Price to sales

7.06

Price against revenue

highWhat this means

Price against revenue — usable when a company has no profit yet.

The price assumes today's revenue will convert into much more profit later.

EV / EBITDA

19.07

Whole-company value against cash earnings

highWhat this means

Whole-company value, debt included, against cash earnings.

Expensive even before interest, tax and depreciation are considered.

Enterprise value

$343.47B

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

1,558,613,439

Shares the profit is split across

Dividend yield

3.07%

Annual dividend against price

meaningfulWhat this means

Annual dividend as a percentage of the share price.

A substantial part of the total return arrives as income.

TechnicalPrice well above 200-day SMA (strong uptrend); RSI in healthy range (30-70) 100.015%

RSI (14)

56.0

Above 70 overbought, below 30 oversold

neutralWhat this means

A 0–100 momentum gauge over the last 14 sessions.

The middle band, where most trading days sit.

MACD

0.94

Momentum against its own trend

MACD histogram

0.14

Positive is bullish

ADX

17.7

Trend strength; above 25 is a real trend

no clear trendWhat this means

Trend strength, regardless of direction.

Below about 20 the price is ranging rather than trending.

20-day average

$189.29

50-day average

$186.21

200-day average

$171.04

Price vs 50-day

3.48%

Price vs 200-day

12.66%

Bollinger upper

$195.35

Bollinger lower

$183.23

Average true range

4.69

Typical daily trading range

Stochastic %K

84.7

Risk4 measured figures 45.012%

Volatility, annualised

23.30%

How far it swings in a year

normalWhat this means

How far the price typically swings over a year.

A typical range for an individual share.

Beta

0.40

Moves against the wider market

steadier than the marketWhat this means

How much the price moves relative to the wider market.

Tends to move less than the index, in both directions.

Maximum drawdown

-22.78%

Worst peak-to-trough fall

containedWhat this means

The worst peak-to-trough fall in the period measured.

No catastrophic fall in this window.

Risk category

Moderate

The engine's own banding

Analyst view6 measured figures 55.010%

Consensus

None

What covering analysts rate it

Analysts covering

15

Mean price target

$203.80

Highest target

$225.00

Lowest target

$175.00

Implied upside

5.77%

Target against today's price

limitedWhat this means

How far the mean analyst target sits above today's price.

Little headroom to the consensus target.

Price against the S&P 500

180 trading days to 2026-08-25

PM is 33.8% up over the window, against 11.6% up for the S&P 500 — ahead by 22.3 points.
PM +33.8%S&P 500 +11.6%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2025-12-05, so they can be compared directly.
DateClosePM rebasedS&P 500 rebased
2025-12-05$143.98100.0100.0
2025-12-29$159.19110.6100.5
2026-01-21$165.94115.2100.1
2026-02-11$183.10127.2101.0
2026-03-05$166.82115.999.4
2026-03-26$161.15111.994.3
2026-04-17$156.49108.7103.7
2026-05-08$169.58117.8107.7
2026-06-01$171.24118.9110.6
2026-06-23$177.22123.1107.2
2026-07-15$180.88125.6110.2
2026-08-05$188.93131.2112.4

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health65.023%15.0
Growth & momentum70.022%15.4
Valuation25.018%4.5
Technical100.015%15.0
Risk45.012%5.4
Analyst view55.010%5.5
ESG50.00%0.0
Quality score100%60.8

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

D-

60.8 / 100

Identical to the IQInvest grade.

All 64 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
20-day averageTechnical$189.29Yahoo Finance
200-day averageTechnical$171.04Yahoo Finance
50-day averageTechnical$186.21Yahoo Finance
52-week highMarket data$207.76Yahoo Finance
52-week lowMarket data$142.11Yahoo Finance
ADXTechnical17.7Yahoo Finance
Analysts coveringAnalyst view15Yahoo Finance
Average daily returnGrowth & momentum0.08%Yahoo Finance
Average true rangeTechnical4.69Yahoo Finance
Average volumeMarket data5,033,626Yahoo Finance
Best dayGrowth & momentum10.95%Yahoo Finance
BetaRisk0.40Yahoo Finance
Bollinger lowerTechnical$183.23Yahoo Finance
Bollinger upperTechnical$195.35Yahoo Finance
ConsensusAnalyst viewNoneYahoo Finance
Current ratioFinancial health0.98Yahoo Finance
Day highMarket data$192.90Yahoo Finance
Day lowMarket data$189.66Yahoo Finance
Dividend yieldValuation3.07%Yahoo Finance
Earnings growthFinancial health-7.50%Yahoo Finance
EmployeesMarket data84,900Yahoo Finance
Enterprise valueValuation$343.47BYahoo Finance
EV / EBITDAValuation19.07Yahoo Finance
Forward P/EValuation21.02Yahoo Finance
Free cash flowFinancial health$9.71BYahoo Finance
Gross marginFinancial health67.48%Yahoo Finance
Highest targetAnalyst view$225.00Yahoo Finance
Implied upsideAnalyst view5.77%Yahoo Finance
Lowest targetAnalyst view$175.00Yahoo Finance
MACDTechnical0.94Yahoo Finance
MACD histogramTechnical0.14Yahoo Finance
Maximum drawdownRisk-22.78%Yahoo Finance
Mean price targetAnalyst view$203.80Yahoo Finance
OpenMarket data$190.87Yahoo Finance
Operating cash flowFinancial health$14.26BYahoo Finance
Operating marginFinancial health40.00%Yahoo Finance
P/E ratioValuation26.47Yahoo Finance
Payout ratioFinancial health80.73%Yahoo Finance
PEG ratioValuation2.45Yahoo Finance
Previous closeMarket data$191.46Yahoo Finance
Price to bookValuation-34.99Yahoo Finance
Price to salesValuation7.06Yahoo Finance
Price vs 200-dayTechnical12.66%Yahoo Finance
Price vs 50-dayTechnical3.48%Yahoo Finance
Profit marginFinancial health25.56%Yahoo Finance
Quick ratioFinancial health0.47Yahoo Finance
Return on assetsFinancial health14.59%Yahoo Finance
Return, 1 monthGrowth & momentum-3.74%Yahoo Finance
Return, 1 yearGrowth & momentum19.30%Yahoo Finance
Return, 3 monthsGrowth & momentum6.73%Yahoo Finance
Return, 3 yearsGrowth & momentum132.28%Yahoo Finance
Return, 6 monthsGrowth & momentum3.28%Yahoo Finance
Return, year to dateGrowth & momentum22.28%Yahoo Finance
RevenueFinancial health$21.34BYahoo Finance
Revenue growthFinancial health10.40%Yahoo Finance
Risk categoryRiskModerateYahoo Finance
RSI (14)Technical56.0Yahoo Finance
Shares outstandingValuation1,558,613,439Yahoo Finance
Sharpe ratioGrowth & momentum0.79Yahoo Finance
Stochastic %KTechnical84.7Yahoo Finance
Volatility, annualisedRisk23.30%Yahoo Finance
VolumeMarket data661,929Yahoo Finance
Win rateGrowth & momentum55.18%Yahoo Finance
Worst dayGrowth & momentum-8.43%Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more